Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-10-16

Clinical Trial Update: Pharmacodynamic Trial on Rocuronium in Obese Patients [Phase 4]

View source ↗

Summary

A Phase 4 pharmacodynamic trial evaluating rocuronium in obese patients undergoing bariatric surgery has completed. The trial was conducted by Rigshospitalet in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROCURONIUM BROMIDE (ROCURONIUM BROMIDE)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Bariatric Surgery | Phase 4 | Status: COMPLETED